News Release

NYSCF and Personal Genome Project announce availability of fully sequenced stem cell lines

Business Announcement

New York Stem Cell Foundation

New York, NY (January 5, 2017) - The New York Stem Cell Foundation (NYSCF) Research Institute and the Personal Genomes Project (PGP) today announced the availability of a unique new stem cell resource for scientists around the world. The stem cell lines resulting from this collaboration beginning in 2013 between the two organizations will now be available for use by other researchers.

Susan L. Solomon, NYSCF CEO and Co-founder stated, "The stem cell lines resulting from this important collaboration will accelerate research globally. They are a valuable resource for many different types of research and I am pleased that we are able to make this important resource available to the scientific community."

PGP Founder George Church noted that, "This milestone enables PGP, as the first truly open-access human bio-data resource, and as partner with NIST, FDA and NIH-ENCODE, to now put diverse stem cells in the hands of researchers and students worldwide, to develop new tissue and organ systems, to test new therapies and determine the diagnostic significance of millions of previously unknown DNA variations."

Uniquely, most of the stem cell lines available are fully or partially sequenced, making them especially useful in drug development research as well as in other research pursuits. The stem cell lines will be made available to all types of organizations, including academic institutions, pharmaceutical companies, independent research consortia, and non-profit institutes.

PGP participants volunteered to provide skin samples for research that were used by NYSCF Research Institute scientists to turn them into induced pluripotent stem cell lines using the NYSCF Global Stem Cell Array™. The NYSCF Array is an automated robotic technology developed by NYSCF to standardize and scale-up the production of stem cell lines and differentiated cell types. The NYSCF Array enables an over ten-fold increase in stem cell line production with over one third less variability between cells as compared to manual cell line derivation.

The PGP tracks participants genomic data, medical histories, body microbiomes and hundreds of other traits which, in combination with the stem cell lines created by the NYSCF Research Institute, provide a unique and powerful resource to help identify causes of diseases, cures and preventions.

###

Visit http://www.nyscf.org/repository to find stem cell lines that are available.

About PersonalGenomes.org and the Personal Genome Project

PersonalGenomes.org (PG.org) is a non-profit organization working to generate, aggregate and interpret human biological and trait data on an unprecedented scale using open-source, open-access and open-consent frameworks. PersonalGenomes.org's mission is to make a wide spectrum of data about humans accessible to increase biological literacy and improve human health. Its efforts are informed by values encouraging greater transparency and collaboration between researchers and participants. Additionally, PG.org supports the Personal Genome Project (PGP) global network. The first PGP research study was founded at Harvard Medical School in 2005, and PGP sites now exist at leading institutions in three countries. More information is available at http://www.personalgenomes.org.

About The New York Stem Cell Foundation Research Institute

The New York Stem Cell Foundation (NYSCF) Research Institute is an independent organization accelerating cures and better treatments for patients through stem cell research. The NYSCF global community includes over 140 researchers at leading institutions worldwide, including the NYSCF - Druckenmiller Fellows, the NYSCF - Robertson Investigators, the NYSCF - Robertson Stem Cell Prize Recipients, and NYSCF Research Institute scientists and engineers. The NYSCF Research Institute employs over 45 researchers in New York, and is an acknowledged world leader in stem cell research and in developing pioneering stem cell technologies, including the NYSCF Global Stem Cell ArrayTM. NYSCF focuses on translational research in a model designed to overcome the barriers that slow discovery and replace silos with collaboration. For more information, visit http://www.nyscf.org


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.